Thank you, Mr. Chair, and thank you to all the witnesses.
I'm going to start with Ms. O'Gorman.
During this testimony, we heard about two purposes, at least, for ArriveCAN. We heard about advance declaration and we also heard about a public health tool. Can you give us an idea which one of these purposes came first and what the driver was for them?